Innovation
Aqemia: in search of new therapeutic molecules
… already other companies doing it. The complexity lies in testing the activity of these molecules on their therapeutic target, and then testing their non-toxicity," explains Maximilien Levesque. … to 2020, in the fight against SARS-CoV-2, the virus behind COVID-19, at a time when Sanofi's vaccine was still a long …Published on: